Talis Biomedical Corp Buy Hold or Sell Recommendation

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Talis Biomedical Corp is 'Not Rated'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Talis Biomedical Corp given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Talis Biomedical Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Note, we conduct extensive research on individual companies such as Talis and provide practical buy, sell, or hold advice based on investors' constraints. Talis Biomedical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Execute Talis Biomedical Buy or Sell Advice

The Talis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Talis Biomedical Corp. Macroaxis does not own or have any residual interests in Talis Biomedical Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Talis Biomedical's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Talis BiomedicalBuy Talis Biomedical
Not Rated
For the selected time horizon Talis Biomedical Corp has a Risk Adjusted Performance of (0.12), Jensen Alpha of (1.98), Total Risk Alpha of (3.20) and Treynor Ratio of (1.99)
We provide advice to complement the current expert consensus on Talis Biomedical. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Talis Biomedical Corp is not overpriced, please validate all Talis Biomedical fundamentals, including its gross profit and the relationship between the total debt and market capitalization . As Talis Biomedical Corp appears to be a penny stock we also recommend to double-check its number of shares shorted numbers.

Talis Biomedical Trading Alerts and Improvement Suggestions

Talis Biomedical is not yet fully synchronised with the market data
Talis Biomedical has some characteristics of a very speculative penny stock
Talis Biomedical has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 412 K. Net Loss for the year was (62.01 M) with loss before overhead, payroll, taxes, and interest of (149.4 M).
Talis Biomedical Corp currently holds about 165.37 M in cash with (53.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.21.

Talis Biomedical Returns Distribution Density

The distribution of Talis Biomedical's historical returns is an attempt to chart the uncertainty of Talis Biomedical's future price movements. The chart of the probability distribution of Talis Biomedical daily returns describes the distribution of returns around its average expected value. We use Talis Biomedical Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Talis Biomedical returns is essential to provide solid investment advice for Talis Biomedical.
Mean Return
-1.89
Value At Risk
-10.69
Potential Upside
5.32
Standard Deviation
10.50
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Talis Biomedical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Scott Randal W. of 302621 shares of Talis Biomedical subject to Rule 16b-3 [view details]

About Talis Biomedical Buy or Sell Advice

When is the right time to buy or sell Talis Biomedical Corp? Buying financial instruments such as Talis Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Talis Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Gold ETFs Thematic Idea Now

Gold ETFs
Gold ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Gold ETFs theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gold ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Talis Pink Sheet

If you are still planning to invest in Talis Biomedical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talis Biomedical's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio